Gengsheng Yu

704 total citations
9 papers, 66 citations indexed

About

Gengsheng Yu is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Otorhinolaryngology. According to data from OpenAlex, Gengsheng Yu has authored 9 papers receiving a total of 66 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 3 papers in Otorhinolaryngology. Recurrent topics in Gengsheng Yu's work include Receptor Mechanisms and Signaling (3 papers), Head and Neck Cancer Studies (3 papers) and Stress Responses and Cortisol (2 papers). Gengsheng Yu is often cited by papers focused on Receptor Mechanisms and Signaling (3 papers), Head and Neck Cancer Studies (3 papers) and Stress Responses and Cortisol (2 papers). Gengsheng Yu collaborates with scholars based in China and United States. Gengsheng Yu's co-authors include Chide Han, Ke Tong, Yan Gao, Li‐Ling Wu, Nanfeng Fan, Erdan Dong, Yanqiao Zhang, Zhi‐Qiang Wang, Jianyong Chen and Peng Qu and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Dental Research and European Journal of Pharmacology.

In The Last Decade

Gengsheng Yu

8 papers receiving 62 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gengsheng Yu China	5	34	16	16	12	12	9	66
Yuqing Shi China	5	45 1.3×	33 2.1×	14 0.9×	7 0.6×	10 0.8×	16	118
Inm Day United Kingdom	4	41 1.2×	6 0.4×	8 0.5×	9 0.8×	11 0.9×	7	77
Bianca E Suur Sweden	6	41 1.2×	9 0.6×	8 0.5×	4 0.3×	20 1.7×	10	132
Alexandre A. Doueik Canada	6	35 1.0×	33 2.1×	10 0.6×	3 0.3×	17 1.4×	10	104
Jazmín Arteaga‐Vázquez Mexico	6	50 1.5×	7 0.4×	6 0.4×	11 0.9×	12 1.0×	20	86
Jimmy Lam United States	4	36 1.1×	6 0.4×	9 0.6×	3 0.3×	9 0.8×	5	117
D. H. Kim South Korea	3	51 1.5×	13 0.8×	15 0.9×	2 0.2×	8 0.7×	3	93
Victoria Banwell United Kingdom	3	42 1.2×	5 0.3×	11 0.7×	5 0.4×	14 1.2×	3	124
Anita Lavery United Kingdom	4	17 0.5×	21 1.3×	23 1.4×	12 1.0×	14 1.2×	8	59
Chris P. Doe Spain	3	25 0.7×	22 1.4×	6 0.4×	3 0.3×	5 0.4×	3	67

Countries citing papers authored by Gengsheng Yu

Since Specialization

Citations

This map shows the geographic impact of Gengsheng Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gengsheng Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gengsheng Yu more than expected).

Fields of papers citing papers by Gengsheng Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gengsheng Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gengsheng Yu. The network helps show where Gengsheng Yu may publish in the future.

Co-authorship network of co-authors of Gengsheng Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Gengsheng Yu. A scholar is included among the top collaborators of Gengsheng Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gengsheng Yu. Gengsheng Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Tong, Ke & Gengsheng Yu. (2021). Acute recurrent rhabdomyolysis in a Chinese boy associated with a novel compound heterozygous LPIN1 variant: a case report. BMC Neurology. 21(1). 42–42. 6 indexed citations

Hong, Shaodong, Yan Huang, Yunpeng Yang, et al.. (2020). GEM20110714: Final overall survival results of the phase III study of first-line gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma.. Journal of Clinical Oncology. 38(15_suppl). 6521–6521. 3 indexed citations

Chen, Jianyong, et al.. (2020). Septin 9 Methylation in Nasopharyngeal Swabs: A Potential Minimally Invasive Biomarker for the Early Detection of Nasopharyngeal Carcinoma. Disease Markers. 2020. 1–7. 9 indexed citations

Xu, Rui‐Hua, Zhi‐Qiang Wang, Lin Shen, et al.. (2019). S-1 plus oxaliplatin versus S-1 plus cisplatin as first-line treatment for advanced diffuse-type or mixed-type gastric/gastroesophageal junction adenocarcinoma: A randomized, phase 3 trial.. Journal of Clinical Oncology. 37(15_suppl). 4017–4017. 15 indexed citations

Zhang, Li, Gengsheng Yu, Jun Jia, et al.. (2016). Gemcitabine plus cisplatin (GP) versus 5-FU plus cisplatin (FP) as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (NPC): A randomized, open-label, multicenter, phase III trial.. Journal of Clinical Oncology. 34(15_suppl). 6007–6007.

Wu, Li‐Ling, et al.. (2006). Functional α₁-Adrenoceptor Subtypes in Human Submandibular Glands. Journal of Dental Research. 85(3). 251–256. 7 indexed citations

Han, Chide, et al.. (1995). Alterations of α1-adrenoceptor subtypes in the hearts of thyroxine-treated rats. European Journal of Pharmacology. 294(2-3). 593–599. 4 indexed citations

Yu, Gengsheng, Mingzhe Chen, & Qide Han. (1995). Alterations of subtypes of cardiac adrenoceptors in old rat.. PubMed. 16(5). 452–4. 4 indexed citations

Yu, Gengsheng & Chide Han. (1994). Role of α1A - and α1B - Adrenoceptors in Phenylephrine-Induced Positive Inotropic Response in Isolated Rat Left Atrium. Journal of Cardiovascular Pharmacology. 24(5). 745–752. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact